In-situ-topoproteome analysis of cutaneous lymphomas: Perspectives of assistance for dermatohistologic diagnostics by Multi Epitope Ligand Cartography (MELC);In-situ-topoproteom-analyse kutaner lymphome: Perspektiven der unterstützung der dermatohistologischen diagnostik mittels Multi-Epitop-Liganden-Cartographie (MELC)

JDDG - Journal of the German Society of Dermatology

Volumn 6, Issue 12, 2008, Pages 1038-1051

  Bonnekoh, Bernd ^a   Pommer, Ansgar J ^b   Böckelmann, Raik ^a,b   Philipsen, Lars ^c   Hofmeister, Henning ^b   Gollnick, Harald ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b SkinSysTec GmbH   (Germany)

^c MelTec GmbH and Co KG   (Germany)

Author keywords

CD11a; CTCL; Cutaneous T cell lymphoma; Multiplex immunophenotyping; Mycosis fungoides; Proteomics; Ultra high content analysis

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; EPITOPE; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MARKER; T6 ANTIGEN;

ANALYTIC METHOD; ARTICLE; ATOPIC DERMATITIS; BLEACHING; DERMATOLOGY; DONOR; FLUORESCENCE; HISTOLOGY; HUMAN; HUMAN TISSUE; MULTI EPITOPE LIGAND CARTOGRAPHY; MYCOSIS FUNGOIDES; PHENOTYPE; PSORIASIS; SKIN; SKIN BIOPSY; SKIN LYMPHOMA; STAINING; TOPOPROTEOME ANALYSIS; TUMOR CELL; WORLD HEALTH ORGANIZATION;

EID: 57449099893     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2008.06754.x     Document Type: Article

References (30)

1. Perfetto SP, Chattopadhyay PK, Roederer M. Seventeen-colour flow cytometry: unraveling the immune system. Nat Rev Immunol 2004 4 : 648 655.
2. Franssen ME, Boezemann JB, Van de Kerkhof PC, Van Erp PE. Monitoring hyperproliferative disorders in human skin: flow cytometry of changing cytokeratin expression. Cytometry 2004 57B : 32 39.
3. Schubert W. Topological proteomics, toponomics, MELK-technology. Adv Biochem Engin Biotechnol 2003 83 : 189 209.
4. Schubert W, Bonnekoh B, Pommer AJ, Philipsen L, Böckelmann R, Malykh Y, Gollnick H, Friedenberger M, Bode M, Dress AWM. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat Biotechnol 2006 24 : 1270 1278.
5. Murphy RF. Putting proteins on the map (News and Views). Nat Biotechnol 2006 24 : 1223 1224.
6. Zhou M, Veenstra TD. Multiplexed immunofluorescence microscopy for the interrogation of cellular protein complexes. Expert Rev Proteomics 2006 3 : 581 583.
7. Wengenmayr R. Einstein II. dringend gesucht. - Kongressbericht. Max Planck Forschung 2005 3 : 58 64.
8. Chaurand P, Schwartz SA, Caprioli RM. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 2002 6 : 676 681.
9. Schwamborn K, Krieg R, Welmann A. Welche Proteine wohin wandern. Dt Ärztebl 2008 105 : B70 B71.
10. Ecker RC, Steiner GE. Microscopybased multicolor tissue cytometry at the single-cell level. Cytometry 2004 59A : 182 190.
11. Bonnekoh B, Böckelmann R, Pommer AJ, Malykh Y, Philipsen L, Gollnick H. The CD11a binding site of efalizumab in psoriatic skin tissue as analyzed by multiepitope ligand cartography robot technology - Introduction of a novel biological drug-binding biochip assay. Skin Pharmacol Physiol 2007 20 : 96 111.
12. Bonnekoh B, Malykh Y, Böckelmann R, Bartsch S, Pommer AJ, Gollnick H. Profiling lymphocyte subpopulations in peripheral blood under efalizumab treatment of psoriasis by multi epitope ligand cartography (MELC) robot microscopy. Eur J Dermatol 2006 16 : 623 635.
13. Massone C, Kodama K, Kerl H, Cerroni L. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol 2005 29 : 550 560.
14. Stadler R, Kremer A. Kutane maligne Lymphome - Klinik, Diagnostik und Therapiestrategien. UniMed Science, Bremen, 2006.
15. Dummer R, Stadler R, Sterry W. Kutane Lymphome. J Dtsch Dermatol Ges 2007 5 : 605 617.
16. Sterry W. Cutaneous T-cell lymphoma: molecular and cytogenetic findings. Oncology (WillistonPark) 2007 21 (2 Suppl 1 13 17.
17. Willemze R, Jaffe BS, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, DiazPerez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJLM. WHOEORTC classification for cutaneous lymphomas. Blood 2005 105 : 3768 3785.
18. Assaf C, Gellrich S, Steinhoff M, Nashan D, Weisse F, Dippel E, Coors E, Stein A, Gollin P, Henke U, AdamMurati S, Koch A, Klemke CD, Stadler R, Sterry W. Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG). J Dtsch Dermatol Ges 2007 5 : 662 668.
19. Bonnekoh B, Pommer AJ, Böckelmann R, Hofmeister H, Philipsen L, Gollnick H. Topo-proteomic in situ analysis of psoriatic plaque under efalizumab treatment. Skin Pharmacol Physiol 2007 20 : 237 252.
20. Bonnekoh B, Böckelmann R, Pommer AJ, Hofmeister H, Philipsen L, Gollnick H. Macrophages and dendritic cells as accessory innate immunocytes in psoriasis: review of immunophenotypes and perspective of in situ identification by topoproteome analysis using multi epitope ligand cartography. G Ital Dermatol Venereol 2007 142 : 437 448.
21. Nashan D, Faulhaber D, Stander S, Luger TA, Stadler R. Mycosis fungoides: a dermatological masquerader. Br J Dermatol 2007 156 : 1 10.
22. Slater DN. The new World Health OrganizationEuropean Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol 2005 153 : 874 880.
23. Burg G, Kempf W, Cozzio A, Feit J, Willemze R, S-Jaffe E, Dummer R, Berti E, Cerroni L, Chimenti S, DiazPerez JL, Grange F, Harris NL, Kazakov DV, Kerl H, Kurrer M, Knobler R, Meijer CJ, Pimpinelli N, Ralfkiaer E, RusselJones R, Sander C, Santucci M, Sterry W, Swerdlow SH, Vermeer MH, Wechsler J, Whittaker S. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol 2005 32 : 647 674.
24. Bank I, Rapman E, Shapiro R, Schiby G, Goldberg I, Barzilai A, Trau H, Gur H. The epidermotropic mycosis fungoides associated alpha1beta1 integrin (VLA1, CD49a/CD29) is primarily a collagen IV receptor on malignant T cells. J Cutan Pathol 1999 26 : 65 71.
25. Chong BF, Wong HK. Immunobiologics in the treatment of psoriasis. Clin Immunol 2007 123 : 129 138.
26. Goedkoop AY, de Rie MA, Teunissen MBM, Picavet DI, van der Hall PO, Bos JD, Tak PP, Kraan MC. Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis. Arch Dermatol Res 2005 297 : 51 59.
27. Trautmann C, Hahnemann HG, Hilbert ET, Detmar M, Gollnick H, Orfanos CE. Das großzellig-anaplastische Ki-1-positive Lymphom der Haut. Fünf eigene Beobachtungen und Literaturübersicht. Hautarzt 1995 46 : 28 34.
28. Bonnekoh B, Schulz M, Franke I, Gollnick H. Complete remission of a primary cutaneous Bcell lymphoma of the lower leg by firstline monotherapy with the CD20-antibody rituximab. J Cancer Res Clin Oncol 2002 128 : 161 166.
29. Braun FK, Fecker LF, Schwarz C, Walden P, Assaf C, Durkop H, Sterry W, Eberle J. Blockade of death receptormediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells. J Invest Dermatol 2007 127 : 2425 2437.
30. Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH, SuriPayer E. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas. Leukemia 2006 20 : 1123 1129.